MRD / Regn No. : THBC\23-24\07062 Date : 24/06/2026
Patient Name : Gigesh Kumar Age & Gender : 41 Yrs. / Male
Contact No. : 9930565182 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Subjective : T2DM SINCE 2015,ADDING BACK DAPANORM TRIO - HAS TOLERATED IN PAST
Objective : 23-APR-2026 REPORTS,HB-16.8/ HBA1C-5.5%,FBS-79/ PPBS-155,CR-1.01,URICN ACID-4.7,P-2.5,AST-20/ ALT-20,TC-239/ TG-135/ LDL-160/ HDL-52,T3-89.6/ T4-10.92/ TSH-1.240,VITD-53.6/ VITB12-289
Plan : CHECK BLOOD SUGARS - IF POSSIBLE TO REDUCE PG1 FURTHTER,WILL HAVE MEDICAL CLEARANCE IN JULY END  
S# Generic (Trade) Name Route Dosage Usage Duration
1 DAPANORM TRIO 10+100+500 MG ORAL 1-0-0 BBF
 4 MTHS
2 GLUCONORM PG1 FORTE ORAL 1-0-1 BBF / BD
 4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 24/Jul/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: